Recent studies have shown that increased serum hs-CRP levels are closely associated with CHD and can be used to evaluate the patients’ condition and stability.[30–32] CT-1 is a member of the IL-6 family.[33] Many recent studies have demonstrated that CT-1 is closely associated with the development and progression of CHD.[34] Increased CT-1 levels are found in patients with CHD and are associated with disease severity. This evidence concerns the gene IL6 and coronary artery disorder.